Skip to main content

PROVINCIAL DRUG COVERAGE – British Columbia

AS OF January 2025

Coverage is under constant review and is subject to change.

Access to a generic or biosimilar equivalent is generally reported to be identical to that of the relevant brand name medication.

TYPE OF LISTING

BRITISH COLUMBIA COVERAGE

Bisphosphonates

Etidronate

Didronel; Generics Available

Not in Drug Formulary

Alendronate

Fosamax; Generics Available

Regular Benefit (10mg, 70mg); Non-Benefit (5mg)

Fosavance; Generics Available

Regular Benefit (70 mg/5600 IU);
Non-Benefit (70 mg/2800 IU)

Risedronate

Actonel; Generics Available

Regular Benefit (5mg, 35mg); Non-Benefit (150mg)

Actonel; DR

Non-Benefit

Zoledronic Acid

Aclasta; Generics Available

Limited Coverage

SERMs

Raloxifene

Evista; Generics Available

Limited Coverage

Teriparatide (PTH)

Forteo; Generics Available

Non-Benefit

Osnuvo (biosimilar)

Non-Benefit

Denosumab

Prolia

Non-Benefit

Jubbonti (biosimilar)

Limited Coverage

Romosozumab

Evenity

Limited Coverage

© Osteoporosis Canada, 2025
Charitable Registration No. 89551 0931 RR 0001